Prognostic and predictive role of hyponatremia in cancer patients

Abstract

Hyponatremia is the most frequent electrolyte disorder encountered in hospitalized patients. Several studies have demonstrated that hyponatremia is a negative prognostic factor in different clinical scenarios. Noteworthy, not only severe and acute hyponatremia has been associated with an increased risk of mortality, but also moderate of even mild chronic hyponatremia may increase the risk of death. This has been demonstrated in different categories of patients, including cancer patients. There is growing evidence that both progression free survival and overall survival are significantly reduced in cancer patients with hyponatremia compared to patients with normonatremia. One important, and still open, question is whether the worse outcome associated with hyponatremia in cancer patients is directly attributable to the electrolyte disorder itself or might be a sign of the severity of the underlying disease. With regard to this point, some basic research studies suggested that low sodium concentration stimulates per se cancer cells proliferation and invasiveness. Recent clinical evidence appears to indicate that the correction of hyponatremia is an independent and favourable prognostic factor in cancer patients. Admittedly, robust confirmatory data from clinical practice are needed, in order to validate the hypothesis that cancer patients may die for hyponatremia and not just with hyponatremia.

Keywords

Hyponatremia / cancer / mortality / prognosis / vasopressin

References

[1] Upadhyay A,Madias NE.Epidemiology of hyponatremia..Semin Nephrol2009;29:227-38

[2] Kremeike K,Burst V,Kuhr K.Prevalence of hyponatremia in inpatients with incurable and life-limiting diseases and its association with physical symptoms-a retrospective descriptive study..Support Care Cancer2018;26:213-22

[3] Wald R,Price LL.Impact of hospital-associated hyponatremia on selected outcomes..Arch Intern Med2010;170:294-302

[4] Klein L,Leimberger JD,Pinha IL.OPTIME-CHF investigators lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (OPTIME-CHF) study..Circulation2005;111:2454-60

[5] Rusinaru D,Berry C,Whalley GA.MAGGIC investigators: relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis(†): meta-analysis global group in chronic heart failure (MAGGIC)..Eur J Heart Fail2012;14:1139-46

[6] Price JF,Shaddy RE,Goldberg JF.Incidence, severity, and association with adverse outcome of hyponatremia in children hospitalized with heart failure..Am J Cardiol2016;118:1006-10

[7] Waikar SS,Curhan GC.Mortality after hospitalization with mild, moderate, and severe hyponatremia..Am J Med2009;122:857-65 PMCID:PMC3033702

[8] Choi JS,Bae EH,Ahn YK.Prognostic impact of hyponatremia occurring at various time points during hospitalization on mortality in patients with acute myocardial infarction..Medicine (Baltimore)2017;96:e7023 PMCID:PMC5466210

[9] Zilberberg MD,Spalding J,Jones AG.Hyponatremia and hospital outcomes among patients with pneumonia: a retrospective cohort study..BMC Pulm Med2008;8:16 PMCID:PMC2531075

[10] Kim WR,Kremers WK,Kamath PS.Hyponatremia and mortality among patients on the liver-transplant waiting list..N Engl J Med2008;359:1018-26 PMCID:PMC4374557

[11] Fortune B.Ascites, refractory ascites and hyponatremia in cirrhosis..Gastroenterol Rep (Oxf)2017;5:104-12 PMCID:PMC5421465

[12] Sun L,Xiao Q.Association of serum sodium and risk of all-cause mortality in patients with chronic kidney disease: a meta-analysis and sysematic review..Sci Rep2017;7:15949 PMCID:PMC5698308

[13] Zhou XY,Ni SS.Hyponatremia and short-term prognosis of patients with acute pulmonary embolism: a meta-analysis..Int J Cardiol2017;227:251-6

[14] Carcel C,Zheng D,Arima H.Prognostic significance of hyponatremia in acute intracerebral hemorrhage: pooled analysis of the intensive blood pressure reduction in acute cerebral hemorrhage trial studies..Crit Care Med2016;44:1388-94

[15] Terzian C,Piotrowski ZH.Admission hyponatremia in the elderly: factors influencing prognosis..J Gen Intern Med1994;9:89-91

[16] Stelfox HT,Khandwala F,Shahpori R.The epidemiology of intensive care unit-acquired hyponatremia and hypernatraemia in medical-surgical intensive care units..Crit Care2008;12:R162 PMCID:PMC2646327

[17] Martin JY,Urban RR.Preoperative hyponatremia in women with ovarian cancer: an additional cause for concern?.Gynecol Oncol2016;142:471-6 PMCID:PMC5892826

[18] Kagase A,Shimura T,Kano S.Impact of pre-procedural hyponatremia on clinical outcomes after transcatheter aortic valve replacement: a propensity-matched analysis..Catheter Cardiovasc Interv2018;92:E125-34

[19] Corona G,Parenti G,Verbalis JG.Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis..PLoS One2013;8:e80451 PMCID:PMC3867320

[20] Elsayem A,Parsons HA,Hui D.Predictors of inpatient mortality in an acute palliative care unit at a comprehensive cancer center..Support Care Cancer2010;18:67-76

[21] Doshi SM,Lei X,Salahudeen AK.Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes..Am J Kidney Dis2012;59:222-8

[22] Berardi R,Castagnani M,Marcucci F.Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patient..Support Care Cancer2015;23:3095-101

[23] Castillo JJ,Boklage SH,Tidwell BA.The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients..BMC Cancer2016;16:564 PMCID:PMC4966824

[24] Goldvaser H,Yerushalmi R,Lahav M.Malignancy associated SIADH: characterization and clinical implications..Acta Oncol2016;55:1190-5

[25] Yoon J,Lee YJ.Hyponatremia as an independent prognostic factor in patients with terminal cancer..Support Care Cancer2015;23:1735-40

[26] Liao H,Rong X,Peng Y.Hyponatremia is a potential predictor of progression in radiation-induced brain necrosis: a retrospective study..BMC Neurol2018;18:130 PMCID:PMC6114772

[27] Hsu HH,Tian YC,Kuo MC.Role of serum sodium in assessing hospital mortality in cancer patients with spontaneous tumour lysis syndrome inducing acute uric acid nephropathy..Int J Clin Pract2009;63:751-6

[28] Selmer C,Torp-Pedersen C,Faber J.Hyponatremia, all-cause mortality, and risk of cancer diagnoses in the primary care setting: a large population study..Eur J Intern Med2016;36:36-43

[29] Vasudev NS,Brown SR,Morgan R.Prognostic factors in renal cell carcinoma: association of preoperative sodium concentration with survival..Clin Cancer Res2008;14:1775-81

[30] Jeppesen AN,Donskov F,von der Maase H.Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma..Br J Cancer2010;102:867-72 PMCID:PMC2833254

[31] Furukawa J,Kusuda Y.Hyponatremia as a powerful prognostic predictor for Japanese patients with clear cell renal cell carcinoma treated with a tyrosine kinase inhibitor..Int J Clin Oncol2015;20:351-7

[32] Kim HS,Jun HJ,Park JO.Clinical outcome of gastric cancer patients with bone marrow metastases..Oncology2007;73:192-7

[33] Hsu CY,Hsia CY,Su CW.Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the barcelona clinic liver cancer system..Hepatology2013;57:112-9

[34] Berghmans T,Body JJ.A prospective study on hyponatraemia in medical cancer patients: epidemiology, aetiology and differential diagnosis..Support Care Cancer2000;8:192-7

[35] Chawla A,Nigwekar SU.Mortality and serum sodium: do patients die from or with hyponatremia..Clin J Am Soc Nephrol2011;6:960-5 PMCID:PMC3087791

[36] Shepshelovich D,Klein A,Milo G.The syndrome of inappropriate antidiuretic hormone secretion: distribution and characterization according to etiologies..Eur J Intern Med2015;26:819-24

[37] Berardi R,Newsom-Davis T,Rinaldi S.Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy..Oncotarget.2017;8:23871-9 PMCID:PMC5410351

[38] Penttilä P,Peltola K.Hyponatremia associates with poor outcome in metastatic renal cell carcinoma patients treated with everolimus: prognostic impact..Acta Oncol2018;57:1580-5

[39] Corona G,Verbalis JG,Maggi M.Hyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis..PLoS One2015;10:e0124105 PMCID:PMC4408113

[40] Havard M,Tchénio T.A dormant state modulated by osmotic pressure controls clonogenicity of prostate cancer cells..J Biol Chem2011;286:44177-86 PMCID:PMC3243505

[41] Benvenuti S,Luciani P,Bossio A.Low extracellular sodium causes neuronal distress independently of reduced osmolality in an experimental model of chronic hyponatremia..Neuromolecular Med.2013;15:493-503

[42] Chau LY.Heme oxygenase-1: emerging target of cancer therapy..J Biomed Sci2015;22:22 PMCID:PMC4380252

[43] Yadav B.Selective inhibition of hemeoxygenase-1 as a novel therapeutic target for anticancer treatment..J Nanomedic Nanotechnol2011;S4:5

[44] Bhandari S,Cranston I,Shaw A.A systematic review of known interventions for the treatment of chronic nonhypovolaemic hypotonic hyponatraemia and a meta-analysis of the vaptans..Clin Endocrinol (Oxf)2017;86:761-71

[45] Schrier RW,Gheorghiade M,Verbalis JG.Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia..N Engl J Med2006;355:2099-112

[46] Verbalis JG,Schrier RW,Zhao Q.Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion..Eur J Endocrinol2011;164:725-32 PMCID:PMC3573862